As a part of the process of quality accreditation in Drug Demand Reduction programs, the validation and pilot phase of the criteria for prevention and risk reduction by Latin American countries has begun. This component of the project is led by Costa Rica, through its National Agency, the Costa Rican Drugs Institute (ICD)
Throughout the process, two international meetings are planned. The first two-day meeting will coordinate with the participating countries the implementation of the project and the actions for the implementation of the piloting. This first meeting was celebrated September 27 and 28, 2017 in the city of San José, Costa Rica.
The second meeting, scheduled before the end of this stage of the project, will allow evaluating the process developed and to sanction the final version of the criteria for the countries, as well as the definition of the strategies to incorporate the standards in each country's institutional systems of evaluation.
The final objective is to strengthen the institutional framework in this area, as well as contribute to a collective construction according to the needs and characteristics of the countries of Latin America.
2.2 - Facilitate the validation and endorsement of quality criteria agreed during C1, for programmes implemented in: prevention; treatment, harm reduction; and social (re)integration/ rehabilitation.
WGs created have assessed existing needs in DDR, to allow the definition of specific final contents for activities in Component 2, adjusting them according to different groups of countries
Validated –using a pilot implementation approach-, the quality criteria agreed during COPOLAD I, for programmes implemented in at least 2 areas of DDR
Endorsed the quality criteria agreed during C1 for DDR programmes and validated in COPOLAD II, in at least, 30% of participating CELAC countries